Analyst Ratings for TransMedics Group (TMDX )
TMDX Rating Summary
TMDX Price Target Summary
- Highest: $145.00 (Jefferies)
- Lowest: $65.00 (Stifel)
- Average: $109.27
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$109.27 (+25.6%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
Rating Score: 6.9 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/28/2026 | UBS » Updated 8/5/2026 |
Patrick Wood | New Coverage | Neutral (N/A) |
77.00 (80.00) |
74.28 (87.02) |
17.15% | Details |
| 5/6/2026 | Oppenheimer | Suraj Kalia | Downgrade | Perform (Outperform) |
N/A (N/A) |
94.93 (87.02) |
-8.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
